Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 17 studies | 43% ± 19% | |
oligodendrocyte | 15 studies | 56% ± 17% | |
oligodendrocyte precursor cell | 14 studies | 45% ± 19% | |
endothelial cell | 10 studies | 25% ± 9% | |
adipocyte | 5 studies | 27% ± 7% | |
glial cell | 4 studies | 33% ± 10% | |
fibroblast | 4 studies | 30% ± 7% | |
GABAergic neuron | 3 studies | 22% ± 5% | |
Mueller cell | 3 studies | 18% ± 3% | |
ependymal cell | 3 studies | 41% ± 21% | |
chondrocyte | 3 studies | 33% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 28% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2310.23 | 2642 / 2642 | 100% | 68.07 | 702 / 705 |
breast | 97% | 593.63 | 443 / 459 | 59% | 2.20 | 665 / 1118 |
skin | 61% | 213.37 | 1098 / 1809 | 76% | 10.23 | 360 / 472 |
adrenal gland | 97% | 631.62 | 250 / 258 | 40% | 1.70 | 91 / 230 |
thymus | 94% | 548.20 | 617 / 653 | 41% | 1.27 | 250 / 605 |
ovary | 99% | 1090.59 | 179 / 180 | 29% | 0.99 | 125 / 430 |
esophagus | 69% | 341.74 | 1003 / 1445 | 54% | 1.87 | 99 / 183 |
lung | 80% | 457.59 | 465 / 578 | 41% | 1.40 | 470 / 1155 |
uterus | 96% | 579.04 | 163 / 170 | 21% | 1.01 | 98 / 459 |
prostate | 85% | 424.02 | 209 / 245 | 29% | 0.82 | 145 / 502 |
kidney | 58% | 252.94 | 52 / 89 | 53% | 2.83 | 478 / 901 |
intestine | 77% | 413.51 | 744 / 966 | 24% | 0.84 | 126 / 527 |
bladder | 81% | 360.38 | 17 / 21 | 18% | 0.59 | 89 / 504 |
blood vessel | 98% | 919.62 | 1313 / 1335 | 0% | 0 | 0 / 0 |
adipose | 96% | 737.06 | 1160 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 21% | 62.61 | 69 / 328 | 65% | 2.49 | 116 / 178 |
heart | 82% | 421.04 | 704 / 861 | 0% | 0 | 0 / 0 |
stomach | 42% | 181.66 | 150 / 359 | 34% | 1.25 | 97 / 286 |
eye | 0% | 0 | 0 / 0 | 73% | 6.12 | 58 / 80 |
spleen | 62% | 235.27 | 150 / 241 | 0% | 0 | 0 / 0 |
liver | 3% | 8.41 | 7 / 226 | 17% | 0.65 | 69 / 406 |
tonsil | 0% | 0 | 0 / 0 | 20% | 0.53 | 9 / 45 |
muscle | 17% | 46.79 | 134 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.22 | 2 / 29 |
peripheral blood | 1% | 5.58 | 9 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033227 | Biological process | dsRNA transport |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | RFTN2 |
Protein name | Raftlin family member 2 Raftlin-2 (Raft-linking protein 2) |
Synonyms | C2orf11 |
Description | FUNCTION: Upon bacterial lipopolysaccharide stimulation, mediates clathrin-dependent internalization of TLR4 in dendritic cells, resulting in activation of TICAM1-mediated signaling and subsequent IFNB1 production. May regulate B-cell antigen receptor-mediated signaling. . |
Accessions | Q52LD8 C9J6C2 ENST00000429081.1 ENST00000295049.9 H7BZ31 ENST00000454447.1 |